Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125199872 | 12519987 | 2 | F | 20160527 | 20160802 | 20160630 | 20160823 | PER | US-PFIZER INC-2016283991 | PFIZER | 76.00 | YR | M | Y | 104.78000 | KG | 20160823 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125199872 | 12519987 | 1 | PS | TIKOSYN | DOFETILIDE | 1 | Oral | 250 UG, 2X/DAY, ONCE IN THE MORNING AND ONCE IN THE EVENING | 20931 | 250 | UG | CAPSULE, HARD | BID | ||||||
| 125199872 | 12519987 | 2 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | CAPSULE | QD | ||||||
| 125199872 | 12519987 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | TABLET | |||||||
| 125199872 | 12519987 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | TABLET | |||||||
| 125199872 | 12519987 | 5 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.25 MG, AS NEEDED | 0 | .25 | MG | TABLET | |||||||
| 125199872 | 12519987 | 6 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG, ONCE IN THE EVENING | 0 | .4 | MG | CAPSULE | QD | ||||||
| 125199872 | 12519987 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 125199872 | 12519987 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, 3X/DAY | 0 | 600 | MG | TABLET | TID | ||||||
| 125199872 | 12519987 | 9 | C | WARFARIN | WARFARIN | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 125199872 | 12519987 | 10 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 6.25 MG, 2X/DAY | 0 | 6.25 | MG | TABLET | BID | ||||||
| 125199872 | 12519987 | 11 | C | POVIDONE | POVIDONE | 1 | Oral | UNK , DAILY | 0 | TABLET | |||||||||
| 125199872 | 12519987 | 12 | C | OXYCODONE | OXYCODONE | 1 | Oral | 10/325MG TABLET BY MOUTH ONE EVERY 4-6 HOURS OR AS NEEDED | 0 | TABLET | |||||||||
| 125199872 | 12519987 | 13 | C | OXYCODONE | OXYCODONE | 1 | 0 | TABLET | |||||||||||
| 125199872 | 12519987 | 14 | C | OXYCODONE | OXYCODONE | 1 | 0 | TABLET | |||||||||||
| 125199872 | 12519987 | 15 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | UNK | 0 | |||||||||||
| 125199872 | 12519987 | 16 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | [BUDESONIDE 160 MCG]/ [FORMOTEROL FUMARATE 4.5 MCG], ONCE IN THE MORING ONCE IN THE EVENING, INHALER | 0 | BID | ||||||||||
| 125199872 | 12519987 | 17 | C | LATANOPROST. | LATANOPROST | 1 | Ophthalmic | 0.005 %, ONCE DAILY IN BOTH EYES | 0 | .005 | PCT | EYE DROPS | QD | ||||||
| 125199872 | 12519987 | 18 | C | CPAP machine | 2 | SLEPT WITH IT ALL NIGHT | 0 | ||||||||||||
| 125199872 | 12519987 | 19 | C | OXYGEN. | OXYGEN | 1 | USED MAINLY AT NIGHT, WHENEVER HE LAYS DOWN HE USES IT; TUBES HE PUTS IN HIS NOSE | 0 | |||||||||||
| 125199872 | 12519987 | 20 | C | NITROSTAT | NITROGLYCERIN | 1 | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125199872 | 12519987 | 1 | Atrial fibrillation |
| 125199872 | 12519987 | 2 | Depression |
| 125199872 | 12519987 | 3 | Blood pressure abnormal |
| 125199872 | 12519987 | 5 | Anxiety |
| 125199872 | 12519987 | 6 | Urinary tract disorder |
| 125199872 | 12519987 | 7 | Blood cholesterol abnormal |
| 125199872 | 12519987 | 8 | Neuropathy peripheral |
| 125199872 | 12519987 | 9 | Anticoagulant therapy |
| 125199872 | 12519987 | 10 | Blood pressure abnormal |
| 125199872 | 12519987 | 11 | Tremor |
| 125199872 | 12519987 | 12 | Pain |
| 125199872 | 12519987 | 13 | Back pain |
| 125199872 | 12519987 | 14 | Musculoskeletal pain |
| 125199872 | 12519987 | 15 | Chronic obstructive pulmonary disease |
| 125199872 | 12519987 | 16 | Chronic obstructive pulmonary disease |
| 125199872 | 12519987 | 17 | Glaucoma |
| 125199872 | 12519987 | 18 | Chronic obstructive pulmonary disease |
| 125199872 | 12519987 | 19 | Chronic obstructive pulmonary disease |
| 125199872 | 12519987 | 20 | Chest pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125199872 | 12519987 | Dizziness | |
| 125199872 | 12519987 | Drug dose omission | |
| 125199872 | 12519987 | Gait disturbance | |
| 125199872 | 12519987 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125199872 | 12519987 | 1 | 201512 | 0 | ||
| 125199872 | 12519987 | 2 | 201602 | 0 | ||
| 125199872 | 12519987 | 4 | 201604 | 0 | ||
| 125199872 | 12519987 | 5 | 2013 | 0 | ||
| 125199872 | 12519987 | 6 | 2010 | 0 | ||
| 125199872 | 12519987 | 7 | 2006 | 0 | ||
| 125199872 | 12519987 | 8 | 2012 | 0 | ||
| 125199872 | 12519987 | 9 | 2011 | 0 | ||
| 125199872 | 12519987 | 10 | 2012 | 0 | ||
| 125199872 | 12519987 | 11 | 2013 | 0 | ||
| 125199872 | 12519987 | 12 | 2001 | 0 | ||
| 125199872 | 12519987 | 15 | 2014 | 0 | ||
| 125199872 | 12519987 | 16 | 201512 | 0 | ||
| 125199872 | 12519987 | 17 | 2012 | 0 | ||
| 125199872 | 12519987 | 18 | 201512 | 20160520 | 0 | |
| 125199872 | 12519987 | 19 | 20160401 | 0 |